Pharmaceuticals

0.27%

Overview Valuation Dividends Dividend analysis HGI High-Growth-Investing analysis Levermann Levermann analysis

Price P/E EV/FCF P/S EV/Sales P/B

Updated on:

1Y 3Y 5Y

	Stock	Current	Forward	Range 3Y